Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
February 12, 2021
GSK v. Teva and Induced Infringement by AB-Rated Generics: Where are we now?
February 5, 2021
FDA Appoints Renowned Cybersecurity Researcher to Head Agency's Medical Device Cybersecurity Efforts
February 3, 2021
Implementation of Final Rule Excluding PBM Rebates from Discount Safe Harbor Delayed Until 2023
January 7, 2021
King & Spalding’s FDA and Life Sciences Team Adds Partner in Washington
December 17, 2020
Law360 Names King & Spalding a Product Liability Practice Group of the Year